4AB:FRA
AbbVie Common Stock
€254.00
arrow_downward
-1.01%(-2.60) 1D
Oct 22, 4:08:59 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€251.90
High
€259.00
Low
€250.00
Mkt. cap
503.56B
Avg. vol.
75.00
Volume
113.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
Open
€251.90
High
€259.00
Low
€250.00
Mkt. cap
503.56B
Avg. vol.
75.00
Volume
113.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Reuters
·
1 hour ago
AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination
The Mighty 790 KFGO
·
1 hour ago
AbbVie’s skin disease drug reduces lesions in trial, company eyes weight-loss combination
Investing.com Canada
·
1 hour ago
AbbVie’s lutikizumab meets primary endpoint in phase 3 HS trial By Investing.com
Yahoo Finance
·
2 hours ago
AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com